Work

Ablation of FAS confers allogeneic CD3– CAR T cells with resistance to rejection by T cells and natural killer cells

Year: 2024

Type: article

Source: Nature Biomedical Engineering

DOI: 10.1038/s41551-024-01282-8

Authors: Silvia Menegatti, Sheila Lopez-Cobo, Aurelien Sutra Del Galy, Jaime Fuentealba, Lisseth Silva, Laetitia Perrin, Sandrine Heurtebise-Chrétien, Valentine Pottez-Jouatte, Aurelie Darbois, Nina Burgdorf, Anne-Laure Privat, Albane Simon, Marguerite Laprie-Sentenac, Michael Saitakis, Bryce Wick, Beau R. Webber, Branden S. Moriarity, Olivier Lantz, Sebastian Amigorena, Laurie Menger

Institutions: Inserm, Université Paris Sciences et Lettres, Immunité et Cancer, Institut Curie, Université Paris-Saclay, Institut Gustave Roussy, University of Minnesota, Masonic Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Agence Nationale de la Recherche, Institut Curie

Awards: Paris Sciences et Lettres, Epigenetic re-programming of CAR T cells for solid tumors

OpenAlex ID: W4404486969

FWCI: 5.138

Cites: 44

Cited by: 29

Related to: 10